About Event

mRNA-Based Therapeutics Summit - What's On?

The mRNA industry has welcomed significant advancements in the next generation of mRNA vaccines and therapeutics with applications in indications beyond COVID-19 since the start of the pandemic. Now, the landscape for successful treatments seems limitless, and the future is brighter than ever for mRNA therapies. With the field’s substantial progress, we are delighted to host the mRNA-Based Therapeutics Summit.

Access the 2022 event guide to see what we covered in our second event edition.

What You Missed in 2022

Attendees icon

370+ Attendees from Large Pharma, Biotech & Academia 

Speakers icon

75+ Thought Leading Speakers


5 Dedicated Tracks of Content Across 3 Days

Speakers icon

7+ Hours of Interactive Networking


45+ Deep Dive Case Studies

Attendees icon

2 Biopharma Leaders Fireside Chats

2022 Conference Overview

Pre-Conference Focus Day


  • Advance analytical methods and control strategies for mRNA vaccine and therapeutic development
  • Overcome potency, efficacy and biodistribution challenges of mRNA therapies with novel bioanalytical tools
  • Insights from: Arcturus Therapeutics, Sanofi, Merck & ReCode Therapeutics


  • Establish resilient supply chains and system management
  • Improve cold chain storage technologies for better drug product stability
  • Insights from: Beam Therapeutics, University of North Carolina at Charlotte, Center for Global Development & University of Orléans

Main Conference Days


  • Advance novel engineering approaches for next-generation mRNAs to expand therapeutic applicability
  • Achieve effective and targeted delivery for mRNA- based therapeutics 2.0
  • Insights from: Replicate Bioscience, Turn Biotechnologies, Capricor Therapeutics & Massachusetts Institute of Technology


  • Supercharge the pre-clinical to clinical success of your mRNA-based therapeutics & vaccines
  • Unleash the power of mRNA technology for infectious and rare diseases, CAR-T therapies & beyond
  • Insights from: Moderna, Mercurna, Strand Therapeutics & Cartesian Therapeutics


  • Trailblaze tech transfer and manufacturing for Phase 1 and beyond
  • Achieve consistency and sustainability with manufacturing at scale
  • Insights from: Ultragenyx, Verve Therapeutics, Tessera Therapeutics & King’s College London